
The Wall Street Journal @WSJ
Breaking: Pfizer is in early-stage talks to acquire biotech Seagen, valued at about $30 billion, and its pioneering targeted cancer therapies https://t.co/WvxnOlGLep — PolitiTweet.org
Created
Mon Feb 27 03:13:59 +0000 2023
Likes
75
Retweets
35
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe Wall Street Journal @WSJ
Breaking: Pfizer is in early-stage talks to acquire biotech Seagen, valued at about $30 billion, and its pioneering targeted cancer therapies https://t.co/WvxnOlGLep — PolitiTweet.org